Metabolic syndrome biomarkers predict lung function impairment: A nested case-control study

Bushra Naveed, Michael D. Weiden, Sophia Kwon, Edward J. Gracely, Ashley L. Comfort, Natalia Ferrier, Kusali J. Kasturiarachchi, Hillel W. Cohen, Thomas K. Aldrich, William N. Rom, Kerry Kelly, David J. Prezant, Anna Nolan

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Rationale: Cross-sectional studies demonstrate an association between metabolic syndrome and impaired lung function. Objectives: To define if metabolic syndrome biomarkers are risk factors for loss of lung function after irritant exposure. Methods: A nested case-control study of Fire Department of New York personnel with normal pre-September 11th FEV 1 and who presented for subspecialty pulmonary evaluation before March 10, 2008. We correlated metabolic syndrome biomarkers obtained within 6 months of World Trade Center dust exposure with subsequent FEV 1. FEV 1 at subspecialty pulmonary evaluation within 6.5 years defined disease status; cases had FEV 1 less than lower limit of normal, whereas control subjects had FEV 1 greater thanor equal to lower limit of normal. Measurements and Main Results: Clinical data and serum sampled at the first monitoring examination within 6 months of September 11, 2001, assessed body mass index, heart rate, serum glucose, triglycerides and high-density lipoprotein (HDL), leptin, pancreatic polypeptide, and amylin. Cases and control subjects had significant differences in HDL less than 40 mg/dl with triglycerides greater than or equal to 150 mg/dl, heart rate greater than or equal to 66 bpm, and leptin greater than or equal to 10,300 pg/ml. Each increased the odds of abnormal FEV 1 at pulmonary evaluation by more than two-fold, whereas amylin greater than or equal to 116 pg/ml decreased the odds by 84%, in a multibiomarker model adjusting for age, race, body mass index, and World Trade Center arrival time. This model had a sensitivity of 41%, a specificity of 86%, and a receiver operating characteristic area under the curve of 0.77. Conclusions: Abnormal triglycerides and HDL and elevated heart rate and leptin are independent risk factors of greater susceptibility to lung function impairment after September 11, 2001, whereas elevated amylin is protective. Metabolic biomarkers are predictors of lung disease, and may be useful for assessing risk of impaired lung function in response to particulate inhalation.

Original languageEnglish (US)
Pages (from-to)392-399
Number of pages8
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume185
Issue number4
DOIs
StatePublished - Feb 15 2012

Fingerprint

Case-Control Studies
Biomarkers
Lung
Islet Amyloid Polypeptide
HDL Lipoproteins
Leptin
Triglycerides
Heart Rate
Body Mass Index
Pancreatic Polypeptide
Irritants
Dust
Serum
ROC Curve
Inhalation
Lung Diseases
Area Under Curve
Cross-Sectional Studies
Glucose

Keywords

  • Biologic markers
  • Metabolic syndrome X
  • September 11 terrorist attacks

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Metabolic syndrome biomarkers predict lung function impairment : A nested case-control study. / Naveed, Bushra; Weiden, Michael D.; Kwon, Sophia; Gracely, Edward J.; Comfort, Ashley L.; Ferrier, Natalia; Kasturiarachchi, Kusali J.; Cohen, Hillel W.; Aldrich, Thomas K.; Rom, William N.; Kelly, Kerry; Prezant, David J.; Nolan, Anna.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 185, No. 4, 15.02.2012, p. 392-399.

Research output: Contribution to journalArticle

Naveed, B, Weiden, MD, Kwon, S, Gracely, EJ, Comfort, AL, Ferrier, N, Kasturiarachchi, KJ, Cohen, HW, Aldrich, TK, Rom, WN, Kelly, K, Prezant, DJ & Nolan, A 2012, 'Metabolic syndrome biomarkers predict lung function impairment: A nested case-control study', American Journal of Respiratory and Critical Care Medicine, vol. 185, no. 4, pp. 392-399. https://doi.org/10.1164/rccm.201109-1672OC
Naveed, Bushra ; Weiden, Michael D. ; Kwon, Sophia ; Gracely, Edward J. ; Comfort, Ashley L. ; Ferrier, Natalia ; Kasturiarachchi, Kusali J. ; Cohen, Hillel W. ; Aldrich, Thomas K. ; Rom, William N. ; Kelly, Kerry ; Prezant, David J. ; Nolan, Anna. / Metabolic syndrome biomarkers predict lung function impairment : A nested case-control study. In: American Journal of Respiratory and Critical Care Medicine. 2012 ; Vol. 185, No. 4. pp. 392-399.
@article{d95abc9168004e54902287b49eb8fd00,
title = "Metabolic syndrome biomarkers predict lung function impairment: A nested case-control study",
abstract = "Rationale: Cross-sectional studies demonstrate an association between metabolic syndrome and impaired lung function. Objectives: To define if metabolic syndrome biomarkers are risk factors for loss of lung function after irritant exposure. Methods: A nested case-control study of Fire Department of New York personnel with normal pre-September 11th FEV 1 and who presented for subspecialty pulmonary evaluation before March 10, 2008. We correlated metabolic syndrome biomarkers obtained within 6 months of World Trade Center dust exposure with subsequent FEV 1. FEV 1 at subspecialty pulmonary evaluation within 6.5 years defined disease status; cases had FEV 1 less than lower limit of normal, whereas control subjects had FEV 1 greater thanor equal to lower limit of normal. Measurements and Main Results: Clinical data and serum sampled at the first monitoring examination within 6 months of September 11, 2001, assessed body mass index, heart rate, serum glucose, triglycerides and high-density lipoprotein (HDL), leptin, pancreatic polypeptide, and amylin. Cases and control subjects had significant differences in HDL less than 40 mg/dl with triglycerides greater than or equal to 150 mg/dl, heart rate greater than or equal to 66 bpm, and leptin greater than or equal to 10,300 pg/ml. Each increased the odds of abnormal FEV 1 at pulmonary evaluation by more than two-fold, whereas amylin greater than or equal to 116 pg/ml decreased the odds by 84{\%}, in a multibiomarker model adjusting for age, race, body mass index, and World Trade Center arrival time. This model had a sensitivity of 41{\%}, a specificity of 86{\%}, and a receiver operating characteristic area under the curve of 0.77. Conclusions: Abnormal triglycerides and HDL and elevated heart rate and leptin are independent risk factors of greater susceptibility to lung function impairment after September 11, 2001, whereas elevated amylin is protective. Metabolic biomarkers are predictors of lung disease, and may be useful for assessing risk of impaired lung function in response to particulate inhalation.",
keywords = "Biologic markers, Metabolic syndrome X, September 11 terrorist attacks",
author = "Bushra Naveed and Weiden, {Michael D.} and Sophia Kwon and Gracely, {Edward J.} and Comfort, {Ashley L.} and Natalia Ferrier and Kasturiarachchi, {Kusali J.} and Cohen, {Hillel W.} and Aldrich, {Thomas K.} and Rom, {William N.} and Kerry Kelly and Prezant, {David J.} and Anna Nolan",
year = "2012",
month = "2",
day = "15",
doi = "10.1164/rccm.201109-1672OC",
language = "English (US)",
volume = "185",
pages = "392--399",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "4",

}

TY - JOUR

T1 - Metabolic syndrome biomarkers predict lung function impairment

T2 - A nested case-control study

AU - Naveed, Bushra

AU - Weiden, Michael D.

AU - Kwon, Sophia

AU - Gracely, Edward J.

AU - Comfort, Ashley L.

AU - Ferrier, Natalia

AU - Kasturiarachchi, Kusali J.

AU - Cohen, Hillel W.

AU - Aldrich, Thomas K.

AU - Rom, William N.

AU - Kelly, Kerry

AU - Prezant, David J.

AU - Nolan, Anna

PY - 2012/2/15

Y1 - 2012/2/15

N2 - Rationale: Cross-sectional studies demonstrate an association between metabolic syndrome and impaired lung function. Objectives: To define if metabolic syndrome biomarkers are risk factors for loss of lung function after irritant exposure. Methods: A nested case-control study of Fire Department of New York personnel with normal pre-September 11th FEV 1 and who presented for subspecialty pulmonary evaluation before March 10, 2008. We correlated metabolic syndrome biomarkers obtained within 6 months of World Trade Center dust exposure with subsequent FEV 1. FEV 1 at subspecialty pulmonary evaluation within 6.5 years defined disease status; cases had FEV 1 less than lower limit of normal, whereas control subjects had FEV 1 greater thanor equal to lower limit of normal. Measurements and Main Results: Clinical data and serum sampled at the first monitoring examination within 6 months of September 11, 2001, assessed body mass index, heart rate, serum glucose, triglycerides and high-density lipoprotein (HDL), leptin, pancreatic polypeptide, and amylin. Cases and control subjects had significant differences in HDL less than 40 mg/dl with triglycerides greater than or equal to 150 mg/dl, heart rate greater than or equal to 66 bpm, and leptin greater than or equal to 10,300 pg/ml. Each increased the odds of abnormal FEV 1 at pulmonary evaluation by more than two-fold, whereas amylin greater than or equal to 116 pg/ml decreased the odds by 84%, in a multibiomarker model adjusting for age, race, body mass index, and World Trade Center arrival time. This model had a sensitivity of 41%, a specificity of 86%, and a receiver operating characteristic area under the curve of 0.77. Conclusions: Abnormal triglycerides and HDL and elevated heart rate and leptin are independent risk factors of greater susceptibility to lung function impairment after September 11, 2001, whereas elevated amylin is protective. Metabolic biomarkers are predictors of lung disease, and may be useful for assessing risk of impaired lung function in response to particulate inhalation.

AB - Rationale: Cross-sectional studies demonstrate an association between metabolic syndrome and impaired lung function. Objectives: To define if metabolic syndrome biomarkers are risk factors for loss of lung function after irritant exposure. Methods: A nested case-control study of Fire Department of New York personnel with normal pre-September 11th FEV 1 and who presented for subspecialty pulmonary evaluation before March 10, 2008. We correlated metabolic syndrome biomarkers obtained within 6 months of World Trade Center dust exposure with subsequent FEV 1. FEV 1 at subspecialty pulmonary evaluation within 6.5 years defined disease status; cases had FEV 1 less than lower limit of normal, whereas control subjects had FEV 1 greater thanor equal to lower limit of normal. Measurements and Main Results: Clinical data and serum sampled at the first monitoring examination within 6 months of September 11, 2001, assessed body mass index, heart rate, serum glucose, triglycerides and high-density lipoprotein (HDL), leptin, pancreatic polypeptide, and amylin. Cases and control subjects had significant differences in HDL less than 40 mg/dl with triglycerides greater than or equal to 150 mg/dl, heart rate greater than or equal to 66 bpm, and leptin greater than or equal to 10,300 pg/ml. Each increased the odds of abnormal FEV 1 at pulmonary evaluation by more than two-fold, whereas amylin greater than or equal to 116 pg/ml decreased the odds by 84%, in a multibiomarker model adjusting for age, race, body mass index, and World Trade Center arrival time. This model had a sensitivity of 41%, a specificity of 86%, and a receiver operating characteristic area under the curve of 0.77. Conclusions: Abnormal triglycerides and HDL and elevated heart rate and leptin are independent risk factors of greater susceptibility to lung function impairment after September 11, 2001, whereas elevated amylin is protective. Metabolic biomarkers are predictors of lung disease, and may be useful for assessing risk of impaired lung function in response to particulate inhalation.

KW - Biologic markers

KW - Metabolic syndrome X

KW - September 11 terrorist attacks

UR - http://www.scopus.com/inward/record.url?scp=84857426293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857426293&partnerID=8YFLogxK

U2 - 10.1164/rccm.201109-1672OC

DO - 10.1164/rccm.201109-1672OC

M3 - Article

C2 - 22095549

AN - SCOPUS:84857426293

VL - 185

SP - 392

EP - 399

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 4

ER -